
Price isn't the reason why you're losing deals
At Thirdside, we've conducted hundreds of in-depth B2B buyer interviews with decision makers across multiple industries and company sizes. What we uncovered was that a majority of losses can be attributed—at least in part—to the buyer not feeling understood. This means the sales teams didn't do enough discovery to uncover the right pain points. Instead, they rushed to demo or pitched too soon.
While those mistakes can show up as 'price' or 'competition' in your CRM, the real failure happened far earlier—when no one asked the right questions.
Discovery is the part of the sales process where a rep deeply explores a prospect's needs, goals, constraints, and buying process before making a recommendation. It includes asking open-ended questions, identifying business pain points, understanding stakeholder dynamics, and confirming the technical and political realities of the account. Discovery is about mapping the customer's world to determine how your solution can naturally fit into it.
We've seen what happens when discovery is treated as a formality, not a core competency:
• Sales reps give the same generic pitch, regardless of audience.
• Buyers are unclear how the solution fits into their business.
• 'No decision' becomes the most common pipeline outcome.
• Closed-won accounts show poor adoption—and churn at the first renewal milestone.
These aren't just the result of having a weak sales team. They're the indicators of a missing—or broken—discovery process.
WHAT YOU'RE MISSING (AND WHAT IT'S COSTING YOU)
When discovery is shallow or rushed, companies routinely miss crucial context: the real problem the customer needs solved, the decision-making structure inside the account, the stakeholder friction that could derail the deal, and the technical limitations that might prevent adoption later. And the cost is real: lost deals, wasted pipeline, and silent churn.
For example, one buyer we interviewed said that the sales team never asked about their specific pain points. So it felt like the presentation was meant for an entirely different company. Another buyer said they churned after a year because it took months to realize the product didn't deliver what they needed.
These were discovery failures—plain and simple.
Discovery isn't a checklist or a pre-demo form. It's a discipline. According to a 2022 McKinsey report, successful B2B sales focus less on persuasion and more on helping customers make sense of their needs and navigate internal complexity. Modern customers expect vendors to understand their industry, product, and market challenges and provide informed, consultative engagement throughout the buying journey.
To treat discovery as an ongoing investigation, sales teams must:
• Ask layered, open-ended questions, such as 'What's happening in your business right now that made this a priority?' or 'In past purchases like this, where have things tended to stall internally?'
• Dig into organizational structure, stakeholder incentives, and political friction.
• Understand the 'why now'—and what happens if the buyer does nothing.
• Tailor their pitch only after they've mapped the customer's internal reality.
HOW TO REBUILD DISCOVERY INSIDE YOUR SALES ORG
Whether you're a founder, CRO, or sales enablement lead, rebuilding your discovery motion doesn't require an overhaul. It requires focus. Start here:
1. Systematize the process. Define what good discovery looks like. You can use frameworks like SPIN or MEDDIC, or develop your own around 'fit' and 'friction.'
2. Coach to the early calls. Don't just review late-stage deals. Go upstream. Listen to discovery calls and debrief how questions were asked—and what was missed.
3. Celebrate thoughtful discovery. Do more than rewarding booked meetings or proposals. Celebrate reps who challenge assumptions and uncover deal-saving insight.
4. Ask your buyers. If you're unsure whether your team is truly doing discovery, go straight to the source. Talk to buyers—both those who bought and those who didn't. I can tell you firsthand: it's a goldmine of customer insight.
THE BOTTOM LINE
In B2B, discovery is where trust begins. When it's rushed, skipped, or treated like a checkbox, everything downstream suffers. Your product might be great. Your pitch might be polished. But if your buyer doesn't feel understood, they won't move forward—or they'll move on.
The best teams don't just pitch. They ask. Then they win. Want to know how well your discovery process is really working? Just ask—your buyers will tell you.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
Apple to bring blood oxygen feature to some US watches with software update
By Stephen Nellis SAN FRANCISCO (Reuters) -Apple will bring a blood oxygen measurement feature to some of its watch models via a software update after receiving approval from the U.S. government amid a protracted legal dispute over the technology, it said on Thursday. The move will allow users of Apple Watch Series 9, Series 10, and Apple Watch Ultra 2 in the United States to view their blood oxygen levels on a paired iPhone. It comes after years of legal wrangling with Irvine, California-based Masimo, which has accused Apple of hiring its employees and stealing its pulse oximetry technology after discussing a potential collaboration. Masimo won a ruling at the U.S. International Trade Commission to block imports of watches with the feature, which prompted Apple to remove the feature and set off a lengthy appeals process. The watch models affected Thursday did not have the blood oxygen feature when shipped, but Apple said U.S. Customs had approved the software update. With the update, a user can start a session in the blood oxygen app on Apple Watch, and the Apple Watch sensors will collect data that will be used by the iPhone to calculate and display the levels, Apple said. Apple first introduced pulse oximetry in its Series 6 Apple Watches in 2020. Masimo released its blood oxygen tracking W1 watch in 2022. Masimo convinced the ITC to block imports of Apple's Series 9 and Ultra 2 smartwatches in 2023, based on the commission's determination that Apple's technology for reading blood oxygen levels infringed upon Masimo's patents. Apple temporarily resumed sales of the watches the next day after persuading the Federal Circuit to pause the ban. The Federal Circuit reinstated the ban the next month, leading Apple to remove pulse oximetry capabilities from its watches in the United States. Masimo did not immediately respond to a request for comment.
Yahoo
15 minutes ago
- Yahoo
Hertz Car Sales is Redefining the Test Drive and Expanding its Rent2Buy Program to 100+ Cities Nationwide
Newly added 2025 models now available for 3-day test drives, with no pressure to buy ESTERO, Fla., August 14, 2025--(BUSINESS WIRE)--Hertz Car Sales today announced the nationwide expansion of its popular Hertz Rent2Buy® program to more than 100 cities. As consumers increasingly embrace the "try before you buy" approach—from furniture to fashion—Hertz Car Sales is meeting the moment by redefining the traditional test drive. The Rent2Buy program offers thousands of well-maintained, competitively priced used vehicles—including newly added 2025 models—for an extended test drive. Switch Auto Insurance and Save Today! Great Rates and Award-Winning Service The Insurance Savings You Expect Affordable Auto Insurance, Customized for You Rent2Buy eliminates the pressure and guesswork of traditional car shopping by allowing customers to test drive vehicles at a low daily rate for up to three days before purchasing. In fact, 80% of those who rent through the program choose to buy the vehicle. Customers can browse online, reserve a vehicle, and take it home for a 3-day test rental. The low daily rental fee is completely waived if they decide to buy. "Buying a car is one of life's biggest decisions, and we believe customers deserve more than a spin around the block to make it," said Jeff Adams, Executive Vice President of Hertz Car Sales. "Rent2Buy reflects how we're rethinking every part of the customer experience at Hertz: giving people the time, tools, and transparency to feel confident in their choices. Whether it's testing how a car fits into your daily life or simply making sure it feels right, Rent2Buy puts the power back in the customer's hands, with no pressure and no surprises." How Rent2Buy Works: Choose your car – Browse a wide selection of vehicles online, including newly added 2025 models. Test it for 3 days – Take a complimentary 2-hour test drive or rent the car for up to 3 days at a special low rate. Make it yours – Love the car? Buy it and Hertz will waive the rental charges. In many states, you can even complete the purchase from home. Peace of Mind Comes Standard Every Rent2Buy vehicle is backed by a 12-month/12,000-mile limited powertrain warranty (whichever comes first), 24-hour roadside assistance, travel breakdown protection, and a 7-day/250-mile buy-back guarantee (whichever comes first)*. Because Rent2Buy vehicles are still part of Hertz's active rental fleet, buyers get early access to newer, lower-mileage cars, often priced below Kelley Blue Book Suggested Retail Value. Whether you're looking for a reliable commuter car, a family SUV, or a luxury ride, Hertz Car Sales makes it easy to find the right fit without the pressure. *Terms apply. Visit to learn more. Hertz Hertz Global Holdings Inc. is one of the world's leading car rental and mobility solutions providers. Its subsidiaries and licensees operate the Hertz, Dollar, Thrifty and Firefly vehicle rental brands with more than 11,000 rental locations in 160 countries around the globe, as well as the Hertz Car Sales brand, which offers a range of quality, competitively priced used cars for sale online and at locations across the US, and the Hertz 24/7 car sharing business in Europe. For more information about Hertz, visit View source version on Contacts mediarelations@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
15 minutes ago
- Yahoo
C3 AI downgraded, Capri upgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Top 5 Upgrades: Deutsche Bank upgraded Palo Alto Network (PANW) to Buy from Hold with a price target of $220, up from $200. With the stock underperforming the broader cyber space by 15% year-to-date, investor concerns for Palo Alto are overblown, the firm tells investors in a research note. BofA upgraded Lumentum (LITE) to Neutral from Underperform with a price target of $135, up from $78. Lumentum is refocusing back to its best-of-breed optical component roots while prudently managing its lower margin optical transceiver mix under its relatively new CEO, the firm tells investors. JPMorgan upgraded Capri Holdings (CPRI) to Overweight from Neutral with a price target of $30, up from $24, after meeting with the company. Capri highlighted revenue improvement throughout fiscal 2026 and a growth inflection at Michael Kors in fiscal 2027, the firm tells investors in a research note. Barclays upgraded Corteva (CTVA) to Overweight from Equal Weight with a price target of $84, up from $75. The firm sees the company benefiting from solid acreage growth in Latin America. Corteva's cost savings and innovation are boosting its profitability, the firm says. Goldman Sachs double upgraded CACI (CACI) to Buy from Sell with a price target of $544, up from $407. The firm views CACI as the best positioned in the defense space under the Trump administration. Top 5 Downgrades: Oppenheimer downgraded C3 AI (AI) to Perform from Outperform without a price target. The company announced 'extremely weak' preliminary fiscal Q1 results which imply a 35% sequential revenue decline, the firm tells investors in a research note. Keefe Bruyette downgraded Opendoor Technologies (OPEN) to Underperform from Market Perform with a $1 price target after its Q2 earnings miss. High retail interest may continue to support valuation, but the firm is downgrading the shares on expectation of widening losses in the second half of the year, coupled with uncertainty from the strategy pivot to weigh on the shares, which trade near the high end of historical multiples. Jefferies downgraded On Holding (ONON) to Underperform from Hold with a price target of $40, down from $50. The firm believes 2025 will represent the company's peak sales growth rate. Morgan Stanley downgraded Insmed (INSM) to Equal Weight from Overweight with a price target of $126, up from $112. The firm believes Insmed's current valuation largely captures the drug's near-term opportunity. Wells Fargo downgraded Brown & Brown (BRO) to Equal Weight from Overweight with a price target of $101, down from $104. The company's organic growth will be below peers in the near-term given its over-concentration to the south and property, the firm tells investors in a research note. Top 5 Initiations: Argus initiated coverage of O'Reilly Automotive (ORLY) with a Buy rating and $120 price target. The company has a history of growth and profitability, and the firm estimates 9%-10% EPS growth over the next two years, the firm tells investors in a research note. Goldman Sachs initiated coverage of Akamai (AKAM) with a Sell rating and $67 price target, which represents 5% share downside. The firm believes the company will be challenged to grow consistently in each of its segments. Citi initiated coverage of Travelers (TRV) with a Neutral rating and $291 price target as the firm rolled out coverage in North America insurance, expecting pricing and reinvestment tailwinds to ease but for earnings to remain resilient. The firm also started coverage of AIG (AIG), Arthur J. Gallagher (AJG), Everest Group (EG), Hamilton Insurance (HG), Hartford Financial (HIG), Marsh McLennan (MMC), Allstate (ALL), WTW (WTW) and Aon (AON) with Neutral ratings. Citi started Arch Capital (ACGL), Chubb (CB), Progressive (PGR), RenaissanceRe (RNR), Ryan Specialty (RYAN) and Brown & Brown (BRO) with Buy ratings Stephens initiated coverage of QXO (QXO) with an Overweight rating and $29 price target. Following the acquisition of Beacon earlier this year, QXO is now the second largest distributor of roofing and complementary products in North America, notes the firm, which believes shares do not fully reflect the successful execution of M&A and organic growth targets that it views as 'achievable.' BofA initiated coverage of Karat Packaging (KRT) with a Neutral rating and $28 price target. While the firm likes Karat's approach as it has transitioned to focusing on distribution from growing manufacturing, it views the shares as fairly valued. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on PANW: Disclaimer & DisclosureReport an Issue Positive Outlook for Palo Alto Networks Amid Strategic Acquisitions and Strong Cybersecurity Market Palo Alto Networks upgraded to Buy from Hold at Deutsche Bank 2 Top Wall Street Analysts Upgrade Palo Alto Stock (PANW) Ahead of Q4 Earnings Intel CEO meets with Trump, Cardinal Health to acquire Solaris: Morning Buzz Starbucks upgraded, Shopify downgraded: Wall Street's top analyst calls Sign in to access your portfolio